Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli.

Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli. Abstract Text:

Juan C Aon,Richard J Caimi,Alexander H Taylor,Quinn Lu,Femi Oluboyede,Jennifer Dally,Michelle D Kessler,John J Kerrigan,Tia S Lewis,Lisa A Wysocki,Pramatesh S Patel,Juan C Aon,Richard J Caimi,Alexander H Taylor,Quinn Lu,Femi Oluboyede,Jennifer Dally,Michelle D Kessler,John J Kerrigan,Tia S Lewis,Lisa A Wysocki,Pramatesh S Patel,

Minimization of chemical modifications during the production of proteins for pharmaceutical and medical applications is of fundamental and practical importance. The gluconoylation of heterologously expressed protein which is observed in Escherichia coli BL21(DE3) constitutes one such undesired posttranslational modification. We postulated that formation of gluconoylated/phosphogluconoylated products of heterologous proteins is caused by the accumulation of 6-phosphogluconolactone due to the absence of phosphogluconolactonase (PGL) in the pentose phosphate pathway. The results obtained demonstrate that overexpression of a heterologous PGL in BL21(DE3) suppresses the formation of the gluconoylated adducts in the therapeutic proteins studied. When this E. coli strain was grown in high-cell-density fed-batch cultures with an extra copy of the pgl gene, we found that the biomass yield and specific productivity of a heterologous 18-kDa protein increased simultaneously by 50 and 60%, respectively. The higher level of PGL expression allowed E. coli strain BL21(DE3) to satisfy the extra demand for precursors, as well as the energy requirements, in order to replicate plasmid DNA and express heterologous genes, as metabolic flux analysis showed by the higher precursor and NADPH fluxes through the oxidative branch of the pentose phosphate shunt. This work shows that E. coli strain BL21(DE3) can be used as a host to produce three different proteins, a heterodimer of liver X receptors, elongin C, and an 18-kDa protein. This is the first report describing a novel and general strategy for suppressing this nonenzymatic modification by metabolic pathway engineering.

Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli. Publishing Authors By Initials

JC Aon,RJ Caimi,AH Taylor,Q Lu,F Oluboyede,J Dally,MD Kessler,JJ Kerrigan,TS Lewis,LA Wysocki,PS Patel,JC Aon,RJ Caimi,AH Taylor,Q Lu,F Oluboyede,J Dally,MD Kessler,JJ Kerrigan,TS Lewis,LA Wysocki,PS Patel,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Applied and environmental microbiology

VOLUME: 74

Page Numbers: 950-8

Journal Abbreviation: Appl. Environ. Microbiol.

ISSN: 1098-5336

DAY: 14

MONTH: 12

YEAR: 2007

Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7605801

Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli.

AFFILIATION: Microbial and Cell Culture Development, GlaxoSmithKline, 709 Swedeland Road, King of Prussia, PA 19406, USA. juan.c.aon@gsk.com

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Appl Environ Microbiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Suppressing posttranslational gluconoylation of heterologous proteins by metabolic engineering of Escherichia coli Related Publications

• A framework for protein structure classification and identification of novel protein structures.
• A new locus for autosomal dominant amelogenesis imperfecta on chromosome 8q24.3.
• A pharmacophore derived phenytoin analogue with increased affinity for slow inactivated sodium channels exhibits a desired anticonvulsant profile.
• A potential protein-RNA recognition event along the RISC-loading pathway from the structure of A. aeolicus Argonaute with externally bound siRNA.
• A simple method for DNA isolation from clotted blood extricated rapidly from serum separator tubes.
• Acridone Alkaloids and Other Constituents of the Leaves of Atalantia ceylanica.
• Anti-inflammatory effects of isoflavones are dependent on flow and human endothelial cell PPARgamma.
• Computer-assisted scoring of the elevated plus maze.
• Conditional stimulation of type V and VI adenylyl cyclases by G protein betagamma subunits.
• Electrical stimulation to restore vestibular function development of a 3-d vestibular prosthesis.
• Epidermal growth factor receptor pathway targeted therapy in patients with aerodigestive malignancies.
• Expression of PACT is regulated by Sp1 transcription factor.
• Hydroxyamide analogs of propofol exhibit state-dependent block of sodium channels in hippocampal neurons: implications for anticonvulsant activity.
• ICAM-1 cross-linking stimulates endothelial glutathione synthesis.
• Immunohistochemical localization of dopamine receptor subtypes (D1R-D5R) in Alzheimer's disease brain.
• Interaction between glutamate and GABA systems in the integration of sympathetic outflow by the paraventricular nucleus of the hypothalamus.
• Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.
• Pifithrin-alpha enhances chemosensitivity by a p38 mitogen-activated protein kinase-dependent modulation of the eukaryotic initiation factor 4E in malignant cholangiocytes.
• SAGA: a subgraph matching tool for biological graphs.
• Secondary mania of vascular origin in elderly patients: a report of two clinical cases.
• Sterolins ABCG5 and ABCG8: regulators of whole body dietary sterols.
• Tannic acid synergizes the cytotoxicity of chemotherapeutic drugs in human cholangiocarcinoma by modulating drug efflux pathways.
• The MicroRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes.
• The liganding of glycolipid transfer protein is controlled by glycolipid acyl structure.
• The role of emotion in decision-making: a cognitive neuroeconomic approach towards understanding sexual risk behavior.
• Transient state kinetics of transcription elongation by T7 RNA polymerase.
• Trusted and relevant medical knowledge: the promise of information retrieval in biomedicine.
• When you come to a fork in the road, take it: strategy selection in order entry.
• Workflow modeling in critical care: piecing your own puzzle.
• p38 Mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest.